Pfizer Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Thank you for joining us for the next session. I'm Matthew Harrison, one of the biopharma analysts here at Morgan Stanley. I'm very pleased to have Pfizer with us.
Before we get started, I need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at morganstanley.com/research disclosures.
And with us from Pfizer, we have Frank D'Amelio, who's the CFO; and Chris Stevo, who runs IR. I'm going to turn it over to Chris and Frank to get us started.
Thank you, Matthew. So favorite forward-looking statement from us as well. Before we begin, just a quick reminder on forward-looking statements. We'll be making some forward-looking commentary and statements here. And as you're all familiar, actual results could be different from those. Additional information regarding
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
